Gypenosides improve diabetic cardiomyopathy by inhibiting ROS‐mediated NLRP3 inflammasome activation

por Zhang, Hailong, Chen, Xi, Zong, Beibei, Yuan, Hongmin, Wang, Zhizeng, Wei, Yinxiang, Wang, Xuance, Liu, Guangchao, Zhang, Jun, Li, Shulian, Cheng, Guanchang, Wang, Yaohui, Ma, Yuanfang
Publicado 2018